Skip to Content

FDC Ltd 531599

Morningstar Rating
INR 480.75 −0.35 (0.07%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

531599 is trading at a 352% premium.
Price
INR 483.00
Fair Value
INR 214.42
Uncertainty
High
1-Star Price
INR 292.45
5-Star Price
INR 478.63
Economic Moat
Mmffwv
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 531599 is a good fit for your portfolio.

Trading Information

Previous Close Price
INR 481.10
Day Range
INR 473.25483.85
52-Week Range
INR 284.55491.20
Bid/Ask
INR 0.00 / INR 0.00
Market Cap
INR 78.27 Bil
Volume/Avg
13,663 / 11,469

Key Statistics

Price/Earnings (Normalized)
30.24
Price/Sales
4.13
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield
1.99%

Company Profile

FDC Ltd is an Indian-based pharmaceutical company with USFDA and UK-MHRA-approved API and formulations manufacturing facilities. It has its presence in numerous therapeutic segments: Anti-infectives, Gastro-Intestinal, Vitamins/Minerals/Nutrients, Ophthalmology/Otologicals, Cardiac, Dermatology, Respiratory, Gynaecology, and Others. The company's brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm. The majority of the revenue is generated domestically.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Mid Core
Total Number of Employees
6,452

Comparables

Valuation

Metric
531599
524348
543434
Price/Earnings (Normalized)
30.2426.4924.81
Price/Book Value
3.973.524.03
Price/Sales
4.131.785.58
Price/Cash Flow
33.9820.0428.34
Price/Earnings
531599
524348
543434

Financial Strength

Metric
531599
524348
543434
Quick Ratio
1.700.913.14
Current Ratio
3.041.666.26
Interest Coverage
95.608.03192.48
Quick Ratio
531599
524348
543434

Profitability

Metric
531599
524348
543434
Return on Assets (Normalized)
7.10%
Return on Equity (Normalized)
13.89%
Return on Invested Capital (Normalized)
10.74%
Return on Assets
531599
524348
543434
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ZTS
Zoetis Inc Class AXrykjhfrMlkrb$79.4 Bil
MKKGY
Merck KGaA ADRLpmvsnjgyYhxlsp$78.2 Bil
HLN
Haleon PLC ADRWmfkhwlbkPhgl$38.5 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRPsfqynnxjQzxz$17.7 Bil
VTRS
Viatris IncMbqmfbnwbDwmvf$13.1 Bil
RDY
Dr Reddy's Laboratories Ltd ADRKkrgrklsBkbf$11.6 Bil
CTLT
Catalent IncFqsrqkhrmKmdhh$10.0 Bil
CURLF
Curaleaf Holdings IncJbxqvxvnjRyrp$4.2 Bil
PRGO
Perrigo Co PLCNsbbpmggZrc$4.1 Bil
PBH
Prestige Consumer Healthcare IncWnfrsslQkffm$3.2 Bil

Sponsor Center